Publications by authors named "Martin S Tallman"

100Publications

Leukapheresis for the management of hyperleukocytosis in acute myeloid leukemia-A systematic review and meta-analysis.

Transfusion 2020 Aug 10. Epub 2020 Aug 10.

Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/trf.15994DOI Listing
August 2020

Interferon Therapy in Myelofibrosis: Systematic Review and Meta-analysis.

Clin Lymphoma Myeloma Leuk 2020 May 28. Epub 2020 May 28.

Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2020.05.018DOI Listing
May 2020

How I treat relapsed or refractory AML.

Blood 2020 Aug;136(9):1023-1032

Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; and.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood.2019001982DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7453152PMC
August 2020

A novel PrECOG (PrE0901) dose-escalation trial using eltrombopag: enhanced platelet recovery during consolidation therapy in acute myeloid leukemia.

Leuk Lymphoma 2020 Sep 30;61(9):2191-2199. Epub 2020 May 30.

Department of Medicine, University Hospitals Cleveland Medical Center, Case Western Reserve University, Cleveland, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2020.1762878DOI Listing
September 2020

Hypofibrinogenemia and disseminated intravascular coagulation rarely complicate treatment-naïve acute lymphoblastic leukemia.

Leuk Lymphoma 2020 May 18:1-5. Epub 2020 May 18.

Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2020.1765236DOI Listing
May 2020

Spontaneous Remission in a Patient With Acute Myeloid Leukemia Leading to Undetectable Minimal Residual Disease.

J Hematol 2020 Apr 23;9(1-2):18-22. Epub 2020 Apr 23.

Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, NYC, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.14740/jh606DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7188378PMC
April 2020

Outcomes of allogeneic stem cell transplantation for patients with t(6:9) AML- A strong case for allogeneic stem cell transplantation in first complete remission.

Br J Haematol 2020 Jun 30;189(5):806-808. Epub 2020 Jan 30.

Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.16478DOI Listing
June 2020

Acute promyelocytic leukemia (APL): remaining challenges towards a cure for all.

Leuk Lymphoma 2019 12 16;60(13):3107-3115. Epub 2019 Dec 16.

Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2019.1613540DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7479633PMC
December 2019

Asciminib in Chronic Myeloid Leukemia after ABL Kinase Inhibitor Failure.

N Engl J Med 2019 12;381(24):2315-2326

From the South Australian Health and Medical Research Institute and the University of Adelaide, Adelaide, SA, Australia (T.P.H., D.Y., D.M.R.); Memorial Sloan Kettering Cancer Center, New York (M.J.M., M.S.T., J.H.P.); University of Texas M.D. Anderson Cancer Center, Houston (J.E.C.); Kobe University Graduate School of Medicine, Kobe (H.M.), and the National Cancer Center Hospital East, Chiba (Y.M.) - both in Japan; Hôpital Saint-Louis, Paris (D.R.), and the University of Bordeaux, Bordeaux (F.-X.M.) - both in France; Dana-Farber Cancer Institute, Boston (D.J.D.); Sapienza University, Rome (M.B.); Singapore General Hospital, Singapore (Y.-T.G.); University of Michigan Comprehensive Cancer Center, Ann Arbor (M.T.); Universitätsklinikum Jena, Jena (A.H.), Charité Hospital, Berlin (P.C.), and the Department for Hematology-Oncology, Goethe University Hospital, Frankfurt am Main (F.L.) - all in Germany; University of Cardiff, Cardiff, United Kingdom (O.O.); Veterans Affairs Portland Health Care System (M.C.H.) and Oregon Health and Science University Knight Cancer Institute (M.C.H., B.J.D.), Portland; Hospital de la Princesa and Instituto de Investigación Sanitaria Princesa, Madrid (J.L.S.); Huntsman Cancer Institute, University of Utah, Salt Lake City (M.W.N.D.); Amsterdam University Medical Centers, VU University Medical Center, Amsterdam (J.J.W.M.J.); Novartis Pharma, Basel, Switzerland (D.H., Y.D., C.M., F.H.-P., K.G.V.); and Seoul St. Mary's Hematology Hospital, Catholic University of Korea, Seoul, South Korea (D.-W.K.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1902328DOI Listing
December 2019

Inhibition of the mutated c-KIT kinase in AML1-ETO-positive leukemia cells restores sensitivity to PARP inhibitor.

Blood Adv 2019 12;3(23):4050-4054

Sol Sherry Thrombosis Research Center and Fels Institute for Cancer Research and Molecular Biology, Lewis Katz School of Medicine at Temple University, Philadelphia, PA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/bloodadvances.2019000756DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6963253PMC
December 2019

Two-dimensional speckle-tracking strain detects subclinical cardiotoxicity in older patients treated for acute myeloid leukemia.

Echocardiography 2019 11 8;36(11):2033-2040. Epub 2019 Nov 8.

Division of Cardiovascular Medicine, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/echo.14518DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6874906PMC
November 2019

Differentiation syndrome in acute promyelocytic leukaemia.

Br J Haematol 2019 10 13;187(2):157-162. Epub 2019 Aug 13.

Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.16151DOI Listing
October 2019

The Role of Abnormal Hemostasis and Fibrinolysis in Morbidity and Mortality of Acute Promyelocytic Leukemia.

Semin Thromb Hemost 2019 Sep 1;45(6):612-621. Epub 2019 Aug 1.

Leukemia Service, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0039-1693478DOI Listing
September 2019

Immunotherapy for acute myeloid leukemia: from allogeneic stem cell transplant to novel therapeutics.

Leuk Lymphoma 2019 12 23;60(14):3350-3362. Epub 2019 Jul 23.

Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2019.1639167DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6928392PMC
December 2019

Antibody-based therapy in acute leukemia - beware the risks.

Leuk Lymphoma 2019 07 17;60(7):1608-1609. Epub 2019 Jun 17.

a Department of Medicine , Memorial Sloan Kettering Cancer Center , Leukemia Service , New York , NY , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2019.1608535DOI Listing
July 2019

Molecular and cytogenetic characteristics of myeloid malignancies following luminal gastrointestinal cancer.

Leuk Res 2019 07 24;82:19-23. Epub 2019 May 24.

Department of Medicine, Memorial Sloan Kettering Cancer Center, USA; Division of Hematologic Malignancies, Leukemia Service, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY, 10065, USA; Department of Medicine, Weill Cornell Medical College, 1300 York Ave, New York, NY, 10065, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2019.05.010DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7051794PMC
July 2019

Exciting Times in Acute Myeloid Leukemia.

Authors:
Martin S Tallman

Semin Hematol 2019 04;56(2):83

Memorial Sloan Kettering Cancer Center, Professor of Medicine, Weill Cornell Medical College.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminhematol.2019.03.002DOI Listing
April 2019

Blinatumomab administered concurrently with oral tyrosine kinase inhibitor therapy is a well-tolerated consolidation strategy and eradicates measurable residual disease in adults with Philadelphia chromosome positive acute lymphoblastic leukemia.

Leuk Res 2019 04 23;79:27-33. Epub 2019 Feb 23.

Leukemia Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA; Cellular Therapeutics Center, Department of Medicine, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2019.02.009DOI Listing
April 2019

BRAF in the cross-hairs.

Expert Rev Hematol 2019 03 26;12(3):183-193. Epub 2019 Feb 26.

a Leukemia Service , Memorial Sloan Kettering Cancer Center , New York , NY , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/17474086.2019.1583553DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6614740PMC
March 2019

LeukeMYC prognostication.

Leuk Lymphoma 2019 01 6;60(1):1-2. Epub 2018 Jul 6.

b Memorial Sloan Kettering Cancer Center , New York , NY , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2018.1482547DOI Listing
January 2019

Durable Remissions with Ivosidenib in IDH1-Mutated Relapsed or Refractory AML.

N Engl J Med 2018 Jun 2;378(25):2386-2398. Epub 2018 Jun 2.

From the University of Texas M.D. Anderson Cancer Center, Houston (C.D.D., H.M.K.); Memorial Sloan Kettering Cancer Center (E.M.S., M.S.T.) and Weill Cornell Medical College (G.J.R.), New York; Institut Gustave Roussy, Villejuif (S.B., C.W.), and Centre Hospitalier Universitaire Bordeaux, Bordeaux (A.P.) - both in France; Northwestern University, Chicago (J.K.A.); Ohio State University Wexner Medical Center, Columbus (A.S.M.); Sylvester Comprehensive Cancer Center, University of Miami, Miami (R.S.); University of Texas Southwestern Medical Center, Dallas (R.H.C.); University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco (G.N.M.), and City of Hope Medical Center, Duarte (A.S.S.) - both in California; University of Colorado School of Medicine, Aurora (D.A.P.); Sarah Cannon Research Institute, Nashville (W.D.); Massachusetts General Hospital Cancer Center (A.T.F.) and Dana-Farber Cancer Institute (R.M.S.), Boston, and Agios Pharmaceuticals, Cambridge (S.C., H.W., V.Z., K.E.Y., S.M.K., H.Y., D.D., B.F., M.G., H.L., S.A., B.W., E.C.A.) - all in Massachusetts; University of Alabama at Birmingham, Birmingham (H.P.E.); Johns Hopkins University, Baltimore (G.T.P.); Washington University School of Medicine, St. Louis (G.L.U.); Mayo Clinic, Jacksonville, FL (J.M.F.); Oregon Health and Science University Knight Cancer Institute, Portland (E.T.); Hollings Cancer Center, Medical University of South Carolina, Charleston (R.K.S.); Winship Cancer Institute of Emory University, Atlanta (M.L.A.); Mayo Clinic, Phoenix, AZ (J.L.S.); and Cleveland Clinic, Cleveland (M.A.S.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1716984DOI Listing
June 2018

Micafungin versus posaconazole prophylaxis in acute leukemia or myelodysplastic syndrome: A randomized study.

J Infect 2018 09 7;77(3):227-234. Epub 2018 May 7.

Infectious Disease Service, Division of Subspecialty Medicine, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weill Cornell Medical College, New York, NY, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jinf.2018.03.015DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6800202PMC
September 2018

Time to repeal and replace response criteria for acute myeloid leukemia?

Blood Rev 2018 09 27;32(5):416-425. Epub 2018 Mar 27.

The Alfred Hospital and Monash University, Melbourne, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.blre.2018.03.006DOI Listing
September 2018

Predictive factors of fatal bleeding in acute promyelocytic leukemia.

Thromb Res 2018 04;164 Suppl 1:S98-S102

Department of Medicine, Hematology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.thromres.2018.01.038DOI Listing
April 2018

Similar incidence of typhlitis in patients receiving various doses of daunorubicin or idarubicin as induction for acute myeloid leukemia.

Leuk Res 2018 05 8;68:48-50. Epub 2018 Mar 8.

Leukemia Service, Division of Hematologic Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2018.03.004DOI Listing
May 2018

Widespread use of measurable residual disease in acute myeloid leukemia practice.

Leuk Res 2018 04 13;67:92-98. Epub 2018 Feb 13.

Department of Medicine, Memorial Sloan Kettering Cancer Center, USA; Division of Hematologic Oncology, Leukemia Service, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY, 10065, USA; Department of Medicine, Weill Cornell Medical College, 1300 York Ave, New York, NY, 10065, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2018.02.006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7029617PMC
April 2018

Choosing for whom to recommend allogeneic transplantation for acute myeloid leukemia in CR1: a continued, complicated conversation.

Blood Adv 2018 01;2(2):164

Department of Medicine and Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY; and Weill Cornell Medical College, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/bloodadvances.2017007674DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5787872PMC
January 2018

Disease characteristics and clinical outcomes in patients aged less than 40 with chronic lymphocytic leukemia.

Leuk Res 2018 02 3;65:80-85. Epub 2018 Jan 3.

Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Weill Cornell Medical College, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2017.12.008DOI Listing
February 2018

New therapeutic strategies for high-risk acute myeloid leukemia.

Curr Opin Hematol 2018 03;25(2):90-94

Memorial Sloan Kettering Cancer Center.

View Article

Download full-text PDF

Source
http://Insights.ovid.com/crossref?an=00062752-900000000-9934
Publisher Site
http://dx.doi.org/10.1097/MOH.0000000000000409DOI Listing
March 2018

Phase 1 study of quizartinib in combination with induction and consolidation chemotherapy in patients with newly diagnosed acute myeloid leukemia.

Am J Hematol 2018 02 4;93(2):213-221. Epub 2017 Dec 4.

Leukemia Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.24974DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6586071PMC
February 2018

Therapy-Related Clonal Hematopoiesis in Patients with Non-hematologic Cancers Is Common and Associated with Adverse Clinical Outcomes.

Cell Stem Cell 2017 09 10;21(3):374-382.e4. Epub 2017 Aug 10.

Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Weill Cornell Medical College, New York, NY 10065, USA; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.stem.2017.07.010DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5591073PMC
September 2017

Digging deeper in relapsed acute lymphoblastic leukemia: impact of MRD status on outcome in second remission.

Leuk Lymphoma 2018 02 28;59(2):269-271. Epub 2017 Jul 28.

a Department of Medicine , Leukemia Service, Memorial Sloan Kettering Cancer Center , New York , NY , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2017.1355971DOI Listing
February 2018

Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation.

N Engl J Med 2017 08 23;377(5):454-464. Epub 2017 Jun 23.

From the Department of Medical Oncology, Dana-Farber Cancer Institute, Boston (R.M.S.); the Division of Biomedical Statistics and Informatics (S.J.M., K.L.) and the Alliance Statistics and Data Center (S.J.M., K.L., S.G.), Mayo Clinic, Rochester, MN; the Alliance Statistics and Data Center, Duke University, Durham, NC (B.L.S.); the Ohio State University Comprehensive Cancer Center, Columbus (S.G., C.D.B., T.W.P., G.M., R.B.K.); Medizinische Klinik und Poliklinik I, Universitätsklinikum Carl Gustav Carus der TU Dresden, Dresden (C.T., G.E.), Department of Internal Medicine III, University Hospital of Ulm, Ulm (K.D., R.F.S., H.D.), Hematology and Oncology, University of Leipzig, Leipzig (D.N.), Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover (J.K., A.G.), and Department of Medicine II, Hematology-Oncology, Goethe University Hospital Frankfurt, Frankfurt am Main (H.S.) - all in Germany; the Department of Biomedicine and Prevention, University Tor Vergata, Rome (F.L.-C., S.A.); the Department of Clinical Haematology, Alfred Hospital and Monash University, Melbourne, VIC, Australia (A.W.); Hospital de la Santa Creu i Sant Pau, Hematology Department, Autonomous University of Barcelona, Barcelona (J.S.), and Hospital Universitario la Fe, Hematology Department, Department of Medicine, University of Valencia, Valencia (M.A.S.) - both in Spain; the Department of Medical Oncology and Hematology, Princess Margaret Hospital, Toronto (J.M.B.); Radboud Institute Molecular Studies, Radboud University Medical Center, Nijmegen, the Netherlands (T.W.); the Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle (F.R.A.); the Division of Hematology-Oncology, Stanford Comprehensive Cancer Center, Stanford University, Stanford, CA (B.C.M.); the Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York (M.S.T.); and the Department of Medicine, University of Chicago, Chicago (R.A.L.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1614359DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5754190PMC
August 2017

Allogeneic Hematopoietic Stem Cell Transplantation Is Underutilized in Older Patients with Myelodysplastic Syndromes.

Biol Blood Marrow Transplant 2017 Jul 20;23(7):1078-1086. Epub 2017 Mar 20.

Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Weill Cornell Medical College, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2017.03.020DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7386429PMC
July 2017

Characteristics features and factors influencing early death in Acute promyelocytic leukemia; Experience from United Arab Emirates (UAE).

Int J Hematol 2017 Jul 14;106(1):90-98. Epub 2017 Mar 14.

Department of Internal Medicine, Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12185-017-2211-7DOI Listing
July 2017

Published abstracts at international meetings often over- or underestimate the initial response rate.

Blood 2017 04 6;129(16):2326-2328. Epub 2017 Mar 6.

Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2017-01-763144DOI Listing
April 2017